An Interview with Gerhard Kinas (Founder of
Kinas Medical Technologies) by: Graciella Davi / Lennard Goetze
Shockwave therapy, a cutting-edge, non-invasive treatment (sometimes also referred to as acoustic wave therapy) has emerged as a game-changer in musculoskeletal care. Known as The Miracle Wave®, this FDA-approved acoustic therapy is backed by decades of research and is widely used to aid in pain management and tissue regeneration. We sat down with Gerhard Kinas, founder of Kinas Medical Technologies, to discuss the evolution, applications, and future potential of this groundbreaking technology.
The Science Behind Shockwave Therapy
Originally developed in the 1980s for breaking up kidney stones in urology, extracorporeal shockwave therapy (ESWT) has since demonstrated remarkable benefits in musculoskeletal healing. "Shockwave therapy has been found to remodel dysfunctional tissue, aiding in tendon injuries, bone healing, and other chronic pain conditions," Kinas explains. Over time, its applications have expanded, proving effective for various orthopedic and sports-related conditions.
 |
click to enlarge |
Common Applications and Clinical BenefitsShockwave therapy is widely used to accelerate healing in chronic tendon injuries, including plantar fasciitis, rotator cuff injuries, and tennis elbow. "Tendons, due to their limited blood supply, often take a long time to heal. Shockwave therapy stimulates the body's own growth factors and stem cells, expediting the regeneration process," says Kinas.
The technology gained significant traction in sports medicine, with Kinas himself introducing it at the 1996 Atlanta Olympics. Today, over 60 professional sports teams across the NFL, NBA, MLB, and NHL use shockwave therapy to keep athletes in peak condition.
Regulatory Approval and Technological DifferentiationShockwave therapy is categorized into focused and radial shockwaves, each with distinct uses. Focused shockwaves, similar to lithotripsy but at lower energy levels, are FDA-approved for specific conditions like plantar fasciitis and diabetic foot ulcers. Radial pressure waves, while not FDA-approved for specific medical indications, are registered for improving blood circulation and relieving muscle tension. "Healthcare providers leverage both technologies for a wide range of pain conditions, ensuring tailored treatment for their patients," Kinas notes.
Scientific Backing and Industry Recognition
With over 9,000 published research papers, shockwave therapy is one of the most extensively studied treatment modalities in regenerative medicine. "It surpasses laser and extracorporeal magnetotransduction therapy (EMTT) in published research, underscoring its credibility and effectiveness," Kinas affirms.
The Evolution and Future of Shockwave TherapyThe journey of shockwave therapy began with its unexpected benefits in orthopedic healing. Initially explored for hip implant procedures, researchers discovered its ability to enhance bone regeneration and reduce pain. This discovery paved the way for broader applications, including treatment for frozen shoulder, epicondylitis, and other conditions where conventional therapies had fallen short.
Kinas Medical continues to innovate, integrating shockwave therapy with complementary technologies like Extracorporeal Magnetotransduction Therapy (EMTT), a non-invasive treatment that uses electromagnetic pulses to stimulate the body's natural healing processes), and on the future horizon Transcranial Pulse Stimulation (TPS), a series of single, ultrashort, and high pressure pulses for non-invasive brain stimulation currently CE approved in Europe only.
Expanding into Preventive Medicine
Beyond pain management, shockwave therapy is being explored for preventive care and performance enhancement. "We envision a future where this technology is not just used for treating injuries but also for preventing them," says Kinas. Research into applications for neurodegenerative diseases, such as Alzheimer's, is ongoing, though regulatory clearance in the U.S. is still in progress.
ConclusionShockwave therapy has established itself as a powerful tool in modern medicine, offering a non-invasive, research-backed solution for chronic pain and tissue regeneration. Under the leadership of Gerhard Kinas, Kinas Medical is at the forefront of advancing this technology, ensuring that patients and healthcare providers continue to benefit from its transformative potential. As research progresses, shockwave therapy is set to redefine the future of musculoskeletal and regenerative medicine.
With over 35 years of experience, GERHARD KINAS has led the expansion of shockwave therapy and other advanced technologies to healthcare providers across the U.S. Early in his career at STORZ MEDICAL AG, he worked directly with product development teams to advance the technology. In 2000, Gerhard founded Kinas Medical Technologies to provide practitioners with clinically proven, non-invasive solutions. Today, Kinas Medical continues to drive healthcare innovation, offering technologies that help providers deliver healing amplified® to their patients, improve outcomes, and support practice growth.
A WORD FROM THE PUBLISHER
The concept of non-invasive health and medical innovations has paved the movement that harnessed the functional medicine community since the '60's -or earlier. Recognizing the science behind SHOCKWAVE helped set the stage to the continued movement that drives today's conventional and personalized /alternative care, pursuing quantitative response to a vast array of disorders. Learning Gerhard Kinas' restorative solutions is an inspiring view of this development for clinicians and researchers alike. Not only does this solution expand our choices for pain management, but it is also (now) being poised as a remarkable preventive option. In addition, knowing about their exploration to address Alzheimer's disease is astonishing to say the least. Regarding scientific evolution, our academic publishing and clinical team highly supports the expansion of this science and applauds the development behind Kinas Medical's shockwave therapy as a viable innovation for consideration in the wellness society. - R. Bard, MD (Founder, AngioMedical Publishing)